Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.15+0.09 (+1.27%)
At close: 01:00PM EST
7.59 +0.44 (+6.15%)
After hours: 03:36PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts8568
Avg. Estimate-0.45-0.51-2.27-0.97
Low estimate-0.55-0.54-2.33-2.36
High estimate-0.22-0.44-2.21-0.09
Year ago EPS-0.52-0.61-0.72-2.27
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts8578
Avg. Estimate6M3.14M10.71M152.7M
Low estimate1.5M1.5M7.65M20M
High estimate16.15M5M21.2M287.6M
Year ago sales7.22M1.49M144.93M10.71M
Sales growth (year/est)-16.90%110.30%-92.60%1,325.80%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.44-0.52-0.6-0.47
Actual EPS-0.52-0.61-0.7-0.49
Difference-0.08-0.09-0.1-0.02
Surprise %-18.20%-17.30%-16.70%-4.30%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.45-0.51-2.27-0.97
7 days ago-0.45-0.51-2.27-0.97
30 days ago-0.43-0.5-2.17-1.08
60 days ago-0.43-0.49-2.17-1.05
90 days ago-0.43-0.49-2.17-1.05
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days6166
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.13.50%N/AN/AN/A
Next qtr.16.40%N/AN/AN/A
Current year-215.30%N/AN/AN/A
Next year57.30%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A